HHS Syndication Storefront

The HHS Syndication Storefront allows you to syndicate (import) content from many HHS websites directly into your own website or application. These services are provided by HHS free of charge.

Search Media Items


Filter results by:
spinner

Newest Syndicated Content

NCI

Cuidados médicos de apoyo en niños (PDQ®)–Versión para profesionales de salud

risk  testing  screening  depression  ovarian  suicide  diagnosis  laboratory  chance  tumor  prostate  staging  markers  targeted  PSA  end-of-life treatment/management  detection  follow-up  marker  5.18 

Resumen de información revisada por expertos acerca de la peculiaridad de los asuntos que surgen durante y después del tratamiento en los niños con cáncer y como sobrevivientes adultos de cáncer.

Preview   0 Users liked this content.
NCI

Tumor Markers

risk  testing  screening  ovarian  diagnosis  laboratory  chance  tumor  prostate  staging  targeted  PSA  prostate cancer  detection  follow-up  marker  5.18  CA 125  Prostate-Specific  American Society of Clinical Oncology 

A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.

Preview   0 Users liked this content.
NCI

ALCHEMIST <span style="font-weight:normal"><i>(The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)</i></span>: Questions and Answers

treatment  trial  drug  screening  lung  tumor  genetic  childhood acute lymphoblastic leukemia  T-cell childhood acute lymphoblastic leukemia  Philadelphia chromosome-positive childhood acute lymphoblastic leukemia  gene  marker  mutation  ALK  EGFR  survival  ALCHEMIST 

ALCHEMIST represents three integrated, precision medicine trials that are designed to identify people with early-stage lung cancer who have tumors that harbor certain uncommon genetic changes and evaluate whether drug treatments targeted against those mol

Preview   0 Users liked this content.
NCI

Prostate-Specific Antigen (PSA) Test

screening  prostate  PSA  detection  prostatic  hyperplasia  marker  BPH  5.29  DRE  density  velocity 

A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.

Preview   0 Users liked this content.
NCI

Prostate-Specific Antigen (PSA) Test

test  antigen  screening  prostate  prostatespecific  PSA  detection  prostatic  hyperplasia  marker  BPH  5.29  DRE  density  velocity 

A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test.

Preview   0 Users liked this content.